In men with metastatic castration- resistant prostate cancer who progressed after docetaxel (Taxotere)-based therapy, treatment with cabazitaxel (Jevtana) was associated with significantly better overall survival compared with mitoxantrone (Novantrone).
The newest urology products and services.
After brachytherapy, 81.3% of men responding to a survey reported successful ejaculation and 90% reported successful orgasm. But the number of men reporting rare ejaculation or no ejaculation at all doubled.
Urologists already often refer to specialists for pain issues.
Diversification gives investors a valuable tool for managing risk and volatility in an investment portfolio. Effective diversification, however, requires diligent maintenance.
Urology drugs and devices that are in the pipeline.
"Lean management" is the latest buzz phrase among savvy medical practices that are trying to reduce costs while improving quality.
Researchers have shed new light on the questionable relationships among prostatitis/chronic pelvic pain syndrome, depression, sexual dysfunction, and lower urinary tract symptoms.
Although active surveillance is not a popular option for men with low-risk prostate cancer, the majority of those who choose it are satisfied with their selection.
Two-year progression-free survival improved significantly in men with castration-resistant prostate cancer treated with toremifene.
Postoperative statin use may offer a potential therapeutic benefit in men with prostate cancer who undergo radical prostatectomy.
It could be time to revisit the idea of using antihistamines and other mast cell inhibitors for interstitial cystitis and even to consider using them for chronic prostatitis/chronic pelvic pain syndrome.
Elspeth M. McDougall, MD, chair of the AUA Office of Education, discusses developing both a curriculum and a training program for robotic surgery in clinical practice.
The increasing popularity of synthetic mesh to treat pelvic organ prolapse has led to a rise in the incidence of certain unique mesh-related complications, including extrusion, erosion, and pain, in a minority of patients. Management of these events is generally straightforward and leads to resolution of bothersome symptoms in the vast majority of patients.
The American Board of Medical Specialties said it intends to create tools to promote the meaningful use of health information technology (HIT) and incorporate them into the ABMS Maintenance of Certification (MOC) program.
Mission Pharmacal Co. has announced the introduction of methenamine, sodium phosphate monobasic, phenyl salicylate, methylene blue, hyoscyamine sulfate (Uribel) capsules for oral administration to help relieve local discomfort and inflammation associated with lower urinary tract infections, interstitial cystitis, painful bladder syndrome, and pre- and post-diagnostic urinary tract procedures.
CO2 laser therapy, used in combination with robotic surgery, may reduce the risk of damaging nerves during prostatectomy, according to a small study by researchers at New York-Presbyterian Hospital/Columbia University Medical Center, New York.
A new study suggests that consuming specific compounds in meat related to processing methods may be associated with an increased risk of developing bladder cancer.
Surgery for localized prostate cancer offers a significantly higher survival rate than either external beam radiation or hormonal therapies, researchers from the University of California, San Francisco recently reported.
UrologyMatch.com, an Internet resource and online community designed to assist medical students, educators, and professionals in all aspects of studying and practicing urology, has launched an application to give users quick and easy access to the most commonly utilized areas of UrologyMatch.com.
A highly specific assay for the detection of a protein associated with tumor formations present in nearly two-thirds of all prostate cancers has shown what researchers are calling unprecedented specificity (99.99%) for detecting prostate tumor cells in tissue specimens.
Most men with prostate cancer who test below the normal PSA level and have low-risk disease still undergo aggressive treatment, researchers from The Cancer Institute of New Jersey, New Brunswick recently reported.
Despite modest increases in compensation experienced by urology and most other specialties, many provider organizations continue to operate at a significant loss, according to findings from the American Medical Group Association?s 2010 Medical Group Compensation and Financial Survey.
The higher your marginal tax bracket, the more likely a tax-free mutual fund will be beneficial.
It is easy to underestimate in good times the consequences of excessive debt and low liquidity when times are tough, however. Like anything else, moderation is the key.
Most full solo family practices have 2,000 to 3,000 patients total in their practices.
For busy clinicians, new technologies promise savings in time as well as costs?in theory. But in practice, is this actually true? The jury is still out.
Statin drugs may lessen the risk for return of prostate cancer in individuals who have undergone radical prostatectomy.
Most biochemical recurrence of prostate cancer following radical prostatectomy occurs within 10 years, and patients who remain free from progression a decade postoperatively can be counseled that their risk of subsequent cancer-related morbidity and mortality is low.